DJE Kapital AG Has $116.11 Million Stock Position in Nutrien Ltd. $NTR

Key Points

• DJE Kapital AG dramatically increased its Nutrien stake in the first quarter, boosting holdings by 1,373.6% to 1,534,869 shares worth about $116.1 million. Nutrien now makes up roughly 2.6% of the fund’s portfolio.
• Nutrien posted better-than-expected quarterly results, reporting EPS of $0.51 versus estimates of $0.48 and revenue of $6.05 billion versus expectations of $5.30 billion. Revenue rose 18.5% year over year.
• The company continues to support shareholders with a dividend, paying a quarterly dividend of $0.55 per share, or $2.20 annually, for a yield of about 3.3%. Analysts currently rate the stock a consensus Moderate Buy with a target price of $82.00.

DJE Kapital AG lifted its stake in Nutrien Ltd. (NYSE:NTR - Free Report) by 1,373.6% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,534,869 shares of the company's stock after purchasing an additional 1,430,708 shares during the period. Nutrien accounts for approximately 2.6% of DJE Kapital AG's holdings, making the stock its 13th largest holding. DJE Kapital AG owned about 0.32% of Nutrien worth $116,111,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in NTR. Madison Asset Management LLC acquired a new position in Nutrien in the first quarter valued at about $987,000. Amova Asset Management Americas Inc. boosted its holdings in Nutrien by 17.9% during the first quarter. Amova Asset Management Americas Inc. now owns 109,543 shares of the company's stock worth $8,262,000 after buying an additional 16,617 shares during the last quarter. Dimensional Fund Advisors LP grew its position in shares of Nutrien by 4.3% during the 1st quarter. Dimensional Fund Advisors LP now owns 5,872,194 shares of the company's stock worth $443,151,000 after buying an additional 239,946 shares during the period. Parallel Advisors LLC grew its position in shares of Nutrien by 71.1% during the 1st quarter. Parallel Advisors LLC now owns 3,081 shares of the company's stock worth $233,000 after buying an additional 1,280 shares during the period. Finally, SEB Asset Management AB bought a new stake in shares of Nutrien in the 1st quarter valued at about $5,124,000. 63.10% of the stock is owned by institutional investors and hedge funds.

Nutrien Trading Down 1.0%

NTR opened at $66.64 on Tuesday. The stock has a market capitalization of $31.88 billion, a P/E ratio of 13.57, a P/E/G ratio of 0.66 and a beta of 0.62. Nutrien Ltd. has a 12 month low of $53.03 and a 12 month high of $85.36. The firm's fifty day simple moving average is $66.80 and its 200 day simple moving average is $69.93. The company has a current ratio of 1.24, a quick ratio of 0.59 and a debt-to-equity ratio of 0.35.

Nutrien (NYSE:NTR - Get Free Report) last released its earnings results on Wednesday, May 6th. The company reported $0.51 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.48 by $0.03. The firm had revenue of $6.05 billion during the quarter, compared to analysts' expectations of $5.30 billion. Nutrien had a return on equity of 8.84% and a net margin of 8.58%.The company's revenue was up 18.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.11 EPS. As a group, research analysts anticipate that Nutrien Ltd. will post 5.11 EPS for the current fiscal year.

Nutrien Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, July 17th. Stockholders of record on Tuesday, June 30th were issued a $0.55 dividend. This represents a $2.20 annualized dividend and a dividend yield of 3.3%. The ex-dividend date of this dividend was Tuesday, June 30th. Nutrien's dividend payout ratio is presently 44.81%.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on NTR. TD Securities reiterated a "buy" rating on shares of Nutrien in a research report on Wednesday, May 6th. Royal Bank Of Canada boosted their price objective on shares of Nutrien from $80.00 to $85.00 and gave the company an "outperform" rating in a report on Tuesday, April 7th. UBS Group lowered their target price on shares of Nutrien from $67.00 to $65.00 and set a "sell" rating for the company in a research note on Monday, May 11th. Scotiabank upgraded shares of Nutrien from a "sector perform" rating to a "sector outperform" rating and set a $80.00 target price on the stock in a report on Tuesday, June 30th. Finally, Canadian Imperial Bank of Commerce reduced their price target on shares of Nutrien from $90.00 to $88.00 and set an "outperformer" rating on the stock in a research report on Thursday, April 30th. Fourteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Nutrien presently has a consensus rating of "Moderate Buy" and a consensus target price of $82.00.

Nutrien Profile

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien's business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.